BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35017463)

  • 1. Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study.
    Chen WJ; Cao H; Cao JW; Zuo L; Qu FJ; Xu D; Zhang H; Gong HY; Chen JX; Ye JQ; Gan SS; Zhou W; Zhu DW; Pan XW; Cui XG
    Cell Death Dis; 2022 Jan; 13(1):50. PubMed ID: 35017463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
    Lv S; Tao L; Liao H; Huang Z; Lu Y
    Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
    Wilson NR; Acikgoz Y; Hasanov E
    Int J Cancer; 2024 Mar; 154(6):947-961. PubMed ID: 37823185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nccRCC: what therapeutic options in 2022?
    Bigot C; Boudier P; Ladoire S; Barthélémy P
    Bull Cancer; 2022 May; 109(2S):2S39-2S46. PubMed ID: 35760469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical analysis of non-clear cell renal cell carcinoma].
    Ohba K; Asai A; Mitsunari K; Matsuo T; Mochizuki Y; Miyata Y; Sakai H
    Hinyokika Kiyo; 2015 Feb; 61(2):43-7. PubMed ID: 25812592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics reveals a low CD8
    Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
    John A; Spain L; Hamid AA
    Curr Oncol; 2023 Jan; 30(1):923-937. PubMed ID: 36661719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?
    Albiges L; Molinie V; Escudier B
    Oncologist; 2012; 17(8):1051-62. PubMed ID: 22807514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Cell Carcinoma-Infiltrating CD3
    Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
    Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.
    Zoumpourlis P; Genovese G; Tannir NM; Msaouel P
    Clin Genitourin Cancer; 2021 Apr; 19(2):103-116. PubMed ID: 33358151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.
    Tannir NM; Plimack E; Ng C; Tamboli P; Bekele NB; Xiao L; Smith L; Lim Z; Pagliaro L; Araujo J; Aparicio A; Matin S; Wood CG; Jonasch E
    Eur Urol; 2012 Dec; 62(6):1013-9. PubMed ID: 22771265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature.
    Ventriglia J; Passarelli A; Pisano C; Cecere SC; Rossetti S; Feroce F; Forte M; Casartelli C; Tambaro R; Pignata S; Perversi F; Di Napoli M
    Crit Rev Oncol Hematol; 2023 Aug; 188():104036. PubMed ID: 37263397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022.
    Maughan BL
    Curr Oncol Rep; 2022 Sep; 24(9):1201-1208. PubMed ID: 35438388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Non-Clear Cell Kidney Cancer: In Search of Rational Treatment Approaches.
    Ornstein MC; Hutson TE
    Cancer J; 2020; 26(5):441-447. PubMed ID: 32947312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.
    McKay RR; Bossé D; Xie W; Wankowicz SAM; Flaifel A; Brandao R; Lalani AA; Martini DJ; Wei XX; Braun DA; Van Allen E; Castellano D; De Velasco G; Wells JC; Heng DY; Fay AP; Schutz FA; Hsu J; Pal SK; Lee JL; Hsieh JJ; Harshman LC; Signoretti S; Motzer RJ; Feldman D; Choueiri TK
    Cancer Immunol Res; 2018 Jul; 6(7):758-765. PubMed ID: 29748390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Atypical Renal Cell Carcinomas.
    Liaw BC; Mehrazin R; Baker C; Sfakianos JP; Tsao CK
    Curr Treat Options Oncol; 2017 Sep; 18(10):61. PubMed ID: 28913767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
    Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
    Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8
    Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z
    Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.